Patients supported for over 4 years with left ventricular assist devices

Evgenij V. Potapov; Michael J. Jurmann; Thorsten Drews; Miralem Pasic; Matthias Loebe; Yuguo Weng; Roland Hetzer

doi:10.1016/j.ejheart.2006.02.003

Patients supported for over 4 years with left ventricular assist devices

Evgenij V. Potapov, Michael J. Jurmann, Thorsten Drews, Miralem Pasic, Matthias Loebe, Yuguo Weng, Roland Hetzer

Academic Institute

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in patients who are not candidates for heart transplantation. This study presents our institution's experience with five patients successfully supported by two different left ventricular assist devices for over 4 years. This unique experience shows that left ventricular assist device support can be extended beyond 4 years with good quality of life and low risk, making it a good alternative for non-transplant candidates.

Original language	English (US)
Pages (from-to)	756-759
Number of pages	4
Journal	European Journal of Heart Failure
Volume	8
Issue number	7
DOIs	https://doi.org/10.1016/j.ejheart.2006.02.003
State	Published - Nov 2006

Keywords

Destination therapy
Heart failure
Heart transplantation
Left ventricular assist device
Non-transplant candidate

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ejheart.2006.02.003

Cite this

@article{a5038b08739d49c48976a833e2b179c3,

title = "Patients supported for over 4 years with left ventricular assist devices",

abstract = "Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in patients who are not candidates for heart transplantation. This study presents our institution's experience with five patients successfully supported by two different left ventricular assist devices for over 4 years. This unique experience shows that left ventricular assist device support can be extended beyond 4 years with good quality of life and low risk, making it a good alternative for non-transplant candidates.",

keywords = "Destination therapy, Heart failure, Heart transplantation, Left ventricular assist device, Non-transplant candidate",

author = "Potapov, {Evgenij V.} and Jurmann, {Michael J.} and Thorsten Drews and Miralem Pasic and Matthias Loebe and Yuguo Weng and Roland Hetzer",

year = "2006",

month = nov,

doi = "10.1016/j.ejheart.2006.02.003",

language = "English (US)",

volume = "8",

pages = "756--759",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Patients supported for over 4 years with left ventricular assist devices

AU - Potapov, Evgenij V.

AU - Jurmann, Michael J.

AU - Drews, Thorsten

AU - Pasic, Miralem

AU - Loebe, Matthias

AU - Weng, Yuguo

AU - Hetzer, Roland

PY - 2006/11

Y1 - 2006/11

N2 - Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in patients who are not candidates for heart transplantation. This study presents our institution's experience with five patients successfully supported by two different left ventricular assist devices for over 4 years. This unique experience shows that left ventricular assist device support can be extended beyond 4 years with good quality of life and low risk, making it a good alternative for non-transplant candidates.

AB - Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in patients who are not candidates for heart transplantation. This study presents our institution's experience with five patients successfully supported by two different left ventricular assist devices for over 4 years. This unique experience shows that left ventricular assist device support can be extended beyond 4 years with good quality of life and low risk, making it a good alternative for non-transplant candidates.

KW - Destination therapy

KW - Heart failure

KW - Heart transplantation

KW - Left ventricular assist device

KW - Non-transplant candidate

UR - http://www.scopus.com/inward/record.url?scp=33745207730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745207730&partnerID=8YFLogxK

U2 - 10.1016/j.ejheart.2006.02.003

DO - 10.1016/j.ejheart.2006.02.003

M3 - Article

C2 - 16556510

AN - SCOPUS:33745207730

VL - 8

SP - 756

EP - 759

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 7

ER -

Patients supported for over 4 years with left ventricular assist devices

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this